Investigational Site Number 620003

Porto 4200-319

0 studies enrolling now · 2 studies all time

What they study most

Hematopoietic Neoplasm, Idiopathic Pulmonary Fibrosis

Studies at this site

• Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis — Completed
• Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis — Completed